This article discusses the risk and opportunities of six major constituents of PJP ETF: Pfizer, Amgen, Gilead, AbbVie, BMY, ...

AbbVie (NYSE: ABBV) recently announced new results from two ongoing clinical trials evaluating epcoritamab, a CD3xCD20 bispecific T-cell-engaging antibody administered subcutaneously, in adult ...

Intramuscular Route Expected to Hold the Largest Share in Viral Vaccines AdministrationDublin, Dec. 26, 2024 (GLOBE NEWSWIRE) -- The "Viral Vaccines Market Size, Share, Forecast, & Trends Analysis by ...

AstraZeneca AZN and its Japanese partner Daiichi Sankyo announced that they have voluntarily withdrawn the marketing ...

Merck will encounter some Keytruda-related issues toward the end of the decade, but the company's business and pipeline are ...

The Ervebo vaccine uses a modified virus to produce antibodies against Ebola ANALYSIS | YAP BOUM | The Ebola virus devastated ...

Merck will discontinue its antibody-drug Zinplava for a bacterial infection that can lead to fatal diarrhea, according to the ...

New Delhi, Dec 26 (PTI) As technological advancements like AI, machine learning and precision medicine revolutionise drug ...

Technological advancements like AI, machine learning and precision medicine are set to revolutionise drug discovery, ...

India's pharmaceutical industry is poised for a dramatic transformation by 2025, driven by AI, machine learning, and precision medicine. Discover how innovation, global access, and quality improvement ...

Germany's peptide therapeutics market is set to grow at a 3.3% CAGR from 2024 to 2034, driven by strong healthcare systems, ...

The "Antibiotic Resistance Therapeutics Market 2025-2029 - Insights by Pathogen and Therapy Type, with Situation Analysis, Executive, and Investor Guides" report has been added to ...